Hepatobiliary Cancers
9
4
4
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
44.4%
4 terminated out of 9 trials
0.0%
-86.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (9)
Observational Study Protocol: LIVER-R
Effect and Mechanism of ALPPS Operation on Liver Regeneration
High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins
Familial Intrahepatic Cholestasis-related Genes Associated with Disease Susceptibility in Hepato-biliary Cancers
Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors
Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers
Genetic Analysis of Liver Cancer